Immunic, Inc. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
Immunic, Inc. (IMUX) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of $9.32 million for the 6-month period ending 2019-06-30, per its 10-Q filed 2019-08-08.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2019-08-08
- Immunic, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2018-06-30 was $143.00K.
- Immunic, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2018-03-31 was -$150.00K.
- Immunic, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-12-31 was -$111.00K.
- Immunic, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-09-30 was -$169.00K.
- Immunic, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2017 was -$678.00K.
- Immunic, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$21.00K.
- Immunic, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$1.28M.
- Immunic, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$2.04M, a 117.13% decline from fiscal 2013.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month as first filed | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 130 month |
|---|---|---|---|---|---|---|
| 2019-06-30 | $9.32M 10-Q · filed 2019-08-08 | |||||
| 2018-06-30 | $143.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$7.00K 10-Q · filed 2019-08-08 | -$332.00K 10-Q · filed 2018-08-07 | -$118.00K derived: sum of 3 quarters · filed 2019-08-08 | -$287.00K derived: sum of 4 quarters · filed 2019-08-08 | |
| 2018-03-31 | -$150.00K 10-Q · filed 2018-05-08 | -$261.00K derived: sum of 2 quarters · filed 2018-05-08 | -$430.00K derived: sum of 3 quarters · filed 2018-05-08 | -$557.00K derived: sum of 4 quarters · filed 2018-08-07 | ||
| 2017-12-31 | -$111.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | -$280.00K derived: sum of 2 quarters · filed 2018-03-13 | -$407.00K derived: sum of 3 quarters · filed 2018-08-07 | -$678.00K 10-K · filed 2018-03-13 | ||
| 2017-09-30 | -$169.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-25 | -$296.00K derived: sum of 2 quarters · filed 2018-08-07 | -$567.00K 10-Q · filed 2017-10-25 | -$668.00K derived: sum of 4 quarters · filed 2018-08-07 | ||
| 2017-06-30 | -$127.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | -$398.00K 10-Q · filed 2018-08-07 | -$499.00K derived: sum of 3 quarters · filed 2018-08-07 | -$550.00K derived: sum of 4 quarters · filed 2018-08-07 | ||
| 2017-03-31 | -$271.00K 10-Q · filed 2018-05-08 | -$372.00K derived: sum of 2 quarters · filed 2018-05-08 | -$423.00K derived: sum of 3 quarters · filed 2018-05-08 | -$382.00K derived: sum of 4 quarters · filed 2018-05-08 | ||
| 2016-12-31 | -$101.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | -$152.00K derived: sum of 2 quarters · filed 2018-03-13 | -$111.00K derived: sum of 3 quarters · filed 2018-03-13 | -$21.00K 10-K · filed 2018-03-13 | ||
| 2016-09-30 | -$51.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-25 | -$10.00K derived: sum of 2 quarters · filed 2017-10-25 | $80.00K 10-Q · filed 2017-10-25 | $568.00K derived: sum of 4 quarters · filed 2018-03-13 | ||
| 2016-06-30 | $41.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $131.00K 10-Q · filed 2017-08-03 | $619.00K derived: sum of 3 quarters · filed 2018-03-13 | $655.00K derived: sum of 4 quarters · filed 2018-03-13 | ||
| 2016-03-31 | $90.00K 10-Q · filed 2017-05-09 | $578.00K derived: sum of 2 quarters · filed 2018-03-13 | $614.00K derived: sum of 3 quarters · filed 2018-03-13 | -$576.00K derived: sum of 4 quarters · filed 2018-03-13 | ||
| 2015-12-31 | $488.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | $524.00K derived: sum of 2 quarters · filed 2018-03-13 | -$666.00K derived: sum of 3 quarters · filed 2018-03-13 | -$1.28M 10-K · filed 2018-03-13 | ||
| 2015-09-30 | $36.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | -$1.15M derived: sum of 2 quarters · filed 2016-11-03 | -$1.77M 10-Q · filed 2016-11-03 | -$1.95M derived: sum of 4 quarters · filed 2017-03-07 | ||
| 2015-06-30 | -$1.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-02 | -$1.80M 10-Q · filed 2016-08-02 | -$1.99M derived: sum of 3 quarters · filed 2017-03-07 | -$2.53M derived: sum of 4 quarters · filed 2017-03-07 | ||
| 2015-03-31 | -$615.00K 10-Q · filed 2016-05-09 | -$798.00K derived: sum of 2 quarters · filed 2017-03-07 | -$1.34M derived: sum of 3 quarters · filed 2017-03-07 | -$1.80M derived: sum of 4 quarters · filed 2017-03-07 | ||
| 2014-12-31 | -$183.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-07 | -$724.00K derived: sum of 2 quarters · filed 2017-03-07 | -$1.19M derived: sum of 3 quarters · filed 2017-03-07 | -$2.04M 10-K · filed 2017-03-07 | ||
| 2014-09-30 | -$541.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | -$1.00M derived: sum of 2 quarters · filed 2015-11-05 | -$1.86M 10-Q · filed 2015-11-05 | -$2.38M derived: sum of 4 quarters · filed 2016-03-08 | ||
| 2014-06-30 | -$463.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | -$1.32M 10-Q · filed 2015-08-06 | -$1.84M derived: sum of 3 quarters · filed 2016-03-08 | $2.44M derived: sum of 4 quarters · filed 2016-03-08 | ||
| 2014-03-31 | -$853.00K 10-Q · filed 2015-05-12 | -$1.38M derived: sum of 2 quarters · filed 2016-03-08 | $2.90M derived: sum of 3 quarters · filed 2016-03-08 | $7.14M derived: sum of 4 quarters · filed 2016-03-08 | -$6.34M 10-Q · filed 2014-05-28 | |
| 2013-12-31 | -$525.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-08 | $3.75M derived: sum of 2 quarters · filed 2016-03-08 | $7.99M derived: sum of 3 quarters · filed 2016-03-08 | $11.91M 10-K · filed 2016-03-08 | ||
| 2013-09-30 | $4.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | $8.52M derived: sum of 2 quarters · filed 2014-11-13 | $12.43M 10-Q · filed 2014-11-13 | |||
| 2013-06-30 | $4.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $8.16M 10-Q · filed 2014-08-07 | ||||
| 2013-03-31 | $3.92M 10-Q · filed 2014-05-28 | |||||
| 2012-12-31 | -$14.59M 10-K · filed 2015-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B |